Evidence map›Paper›PMID 35137455›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

The Notch pathway regulates the bone gain induced by PTH anabolic signaling.

Jesus Delgado-Calle, Kevin McAndrews, Gerald Wu, Ashley L Orr, Adam Ferrari, Xiaolin Tu, Venkatesan Srinivasan, G David Roodman, Frank H Ebetino, Robert K Boeckman and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Upregulation of Parathyroid Hormone Receptor 1 (International journal of molecular sciences · 2026
    Article
  2. Review
  3. Optimizing type H vessels formationBioactive materials · 2025
    Article
  4. Review
  5. Bisphosphonates for osteoporosis: from bench to clinic.The Journal of clinical investigation · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jesus Delgado-CalleDepartment of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID https://orcid.org/0000-0002-2083-2774
Kevin McAndrewsDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gerald WuDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Ashley L OrrDepartment of Medicine, Division of Hematology/Oncology, University of Rochester, Rochester, New York, USA.
Adam FerrariDepartment of Medicine, Division of Hematology/Oncology, University of Rochester, Rochester, New York, USA.
Xiaolin TuDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Venkatesan SrinivasanDepartment of Chemistry, University of Rochester, Rochester, New York, USA.
G David RoodmanDepartment of Medicine, Division of Hematology/Oncology, University of Rochester, Rochester, New York, USA.
Frank H EbetinoDepartment of Chemistry, University of Rochester, Rochester, New York, USA.
Robert K BoeckmanDepartment of Chemistry, University of Rochester, Rochester, New York, USA.
Teresita BellidoDepartment of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.ORCID https://orcid.org/0000-0002-8203-7004
University of Rochester · USIndiana University – Purdue University Indianapolis · USCentral Arkansas Veterans Healthcare System · USWinthrop Rockefeller Foundation · US

Funding

Understanding the Negative Prognostic Impact of Intraosseous Focal Lesions in Multiple MyelomaP20GM125503 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI CHARLES A O'BRIEN · 2018 to 2026
$23.0M
Glucocorticoid-induced Atrophy in Bone and MuscleR01AR059357 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI BELLIDO, TERESITA M. · 2011 to 2022
$3.4M
Bone-Targeted Therapies to Improve Bone Health and Prevent Relapse in Multiple MyelomaR37CA251763 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI DELGADO-CALLE, JESUS · 2020 to 2025
$2.6M
PTH receptor Signaling and Diabetes-induced Bone DiseaseI01BX002104 · VA · RLR VA MEDICAL CENTER · PI BELLIDO, TERESITA M. · 2014 to 2023
–
BLR&D Research Career Scientist Award Application for Teresita Bellido, PhDIK6BX004596 · VA · RLR VA MEDICAL CENTER · PI BELLIDO, TERESITA M. · 2019 to 2025
–
BLRD VA I01 BX002104BLRD VA I01 BX006492BLRD VA IK6 BX004596NCI NIH HHS R37 CA251763NIAMS NIH HHS R01 AR059357NIGMS NIH HHS P20 GM125503
6 · The paper itself

Abstract

Parathyroid hormone (PTH) signaling downstream of the PTH 1 receptor (Pth1r) results in both bone anabolic and catabolic actions by mechanisms not yet fully understood. In this study, we show that Pth1r signaling upregulates the expression of several components of the Notch pathway and that Notch signals contribute to the catabolic actions of PTH in bone. We found that constitutive genetic activation of PTH receptor signaling in osteocytes (caPth1r

Indexed as

OsteogenesisAnimalsBone ResorptionFemaleMiceMice, Inbred C57BLOsteocytesParathyroid HormoneReceptor, Parathyroid Hormone, Type 1Receptors, NotchSignal TransductionParathyroid HormoneReceptor, Parathyroid Hormone, Type 1Receptors, NotchboneNotchosteoblastsosteoclastsosteocytesPTHresorption

Identifiers

PMID35137455
PMCPMC8855690
OpenAlexW4210913420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.